Large bowel recurrence of endometrial adenocarcinoma years after treatment: A single-institution case series and review of the literature
Endometrial cancer (EC) is the most common gynecologic cancer in the United States. A majority of new cases are diagnosed as low-grade International Federation of Gynecology and Obstetrics (FIGO) Stage I, with a recurrence risk cited as less than 9 % in the first 2–3 years post-treatment. In this ca...
Main Authors: | Annalyn M. Welp, Linda R. Duska |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Gynecologic Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578924000158 |
Similar Items
-
The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer
by: Angelina Carey-Love, et al.
Published: (2021-02-01) -
An evaluation of the utility of computed tomography in high-risk endometrial cancer surveillance
by: Taliya Lantsman, et al.
Published: (2024-01-01) -
Gastric mucosa as a rare recurrence location of endometrial endometrioid adenocarcinoma
by: Kathleen Lundeberg, et al.
Published: (2024-06-01) -
Reassessment of intensive surveillance practices adopted for endometrial cancer survivors
by: Kazuto Nakamura, et al.
Published: (2022-08-01) -
Chest wall bone late recurrence of an endometrial adenocarcinoma
by: Zakaria Abide, et al.
Published: (2023-08-01)